Chip woes may derail auto production plans
Business Standard|April 04, 2023
Even as India's passenger vehicle sales touched a record high of 3.9 million units in 2022-23, growing 27 per cent over the previous financial year, the country's largest carmaker, Maruti Suzuki (MSIL), India said on Monday uncertainties in the electronic-component supplies might affect production in FY24.
SOHINI DAS
Chip woes may derail auto production plans

MSIL said the shortage of electronic components had some impact on production in FY23.

"The Company took all possible measures to minimise the impact. As the supply situation of electronic components continues to be unpredictable, it might have some impact on the production volume in FY2023-24 as well," it said in a statement to the stock exchanges.

MSIL produced 1.92 million units in FY23 (including light commercial vehicles), 16 per cent more than the 1.65 million in FY22.

Semiconductor chips have become a significant component in today's cars. A chip can be a simple component containing a transistor, or an integrated circuit that controls a complex system.

Popular sport utility vehicles contain hundreds of semiconductor chips in them, which explains the high waiting period for these cars, especially the higher-end ones.

This story is from the April 04, 2023 edition of Business Standard.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

This story is from the April 04, 2023 edition of Business Standard.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

MORE STORIES FROM BUSINESS STANDARDView All
CDSCO cracks whip on drug units
Business Standard

CDSCO cracks whip on drug units

Shuts down 36% of the 400-odd drug manufacturing facilities for failing to meet quality standards

time-read
2 mins  |
June 28, 2024
Business Standard

USFDA flags drug quality concerns in India

The Center for Drug Evaluation and Research (CDER), a division of the US Food and Drug Administration (FDA), has expressed concern over the quality of drugs manufactured in India, asserting that it found violations at 11 per cent of the facilities it inspected in the country, the highest in any other global region, a senior official said.

time-read
1 min  |
June 28, 2024
Arundhati Roy gets UK's Pen Pinter Prize
Business Standard

Arundhati Roy gets UK's Pen Pinter Prize

Booker Prize-winning author Arundhati Roy, currently facing the threat of prosecution over historic comments on Kashmir 14 years ago, was on Thursday honoured with the prestigious Pen Pinter Prize 2024 for her \"unflinching and unswerving\" writings.

time-read
1 min  |
June 28, 2024
7 YEARS OF GST: MONTHLY COLLECTIONS SURGE 87%
Business Standard

7 YEARS OF GST: MONTHLY COLLECTIONS SURGE 87%

With enhanced revenues, the stage seems set for GST 2.0

time-read
5 mins  |
June 28, 2024
Launches may offer shot in arm for GSK Pharma
Business Standard

Launches may offer shot in arm for GSK Pharma

The stock of GlaxoSmithKline Pharmaceuticals, or GSK Pharma, has risen over 5 per cent in a week.

time-read
2 mins  |
June 28, 2024
Business Standard

700% surge in 6 mths: 25 SME stocks reach for the sky

Stocks of small and medium enterprises (SME) have had a good run at the bourses, with select counters surging more than 700 per cent in calendar year 2024, according to data from ACE Equity.

time-read
2 mins  |
June 28, 2024
Business Standard

Allied Blenders' IPO subscribed 23.5 times

Allied Blenders & Distillers's initial public offering (IPO) was subscribed 23.5 times on Thursday, the concluding day of the issue.

time-read
1 min  |
June 28, 2024
'Tax relief will be big positive for markets'
Business Standard

'Tax relief will be big positive for markets'

All eyes are on Union Budget proposals that will in July show the policy intent of the new government.

time-read
3 mins  |
June 28, 2024
Business Standard

Fairfax group divests 9.7% stake in CSB Bank

Canadian billionaire Prem Watsa's Fairfax group on Thursday divested a 9.7 per cent stake in CSB Bank through its arm FIH Mauritius Investments.

time-read
1 min  |
June 28, 2024
Dr Reddy's in pink of health after Haleon's NRT biz acquisition
Business Standard

Dr Reddy's in pink of health after Haleon's NRT biz acquisition

Dr Reddy's Laboratories (DRL) is set to acquire Haleon's global portfolio of consumer healthcare brands in the nicotine replacement therapy (NRT) category outside of the US.

time-read
2 mins  |
June 28, 2024